Publication:
Serum microRNAs targeting ACE2 and RAB14 genes distinguish asymptomatic from critical COVID-19 patients.

Loading...
Thumbnail Image

Date

2022-06-05

Authors

Calderon-Dominguez, Maria
Trejo-Gutierrez, Eva
Gonzalez-Rovira, Almudena
Beltran-Camacho, Lucia
Rojas-Torres, Marta
Eslava-Alcon, Sara
Sanchez-Morillo, Daniel
Calderon-Dominguez, Juan
Martinez-Nicolas, Mª Pilar
Gonzalez-Beitia, Estibaliz

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Cell Press
Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Despite the extraordinary advances achieved to beat COVID-19 disease, many questions remain unsolved, including the mechanisms of action of SARS-CoV-2 and which factors determine why individuals respond so differently to the viral infection. Herein, we performed an in silico analysis to identify host microRNA targeting ACE2, TMPRSS2, and/or RAB14, all genes known to participate in viral entry and replication. Next, the levels of six microRNA candidates previously linked to viral and respiratory-related pathologies were measured in the serum of COVID-19-negative controls (n = 16), IgG-positive COVID-19 asymptomatic individuals (n = 16), and critical COVID-19 patients (n = 17). Four of the peripheral microRNAs analyzed (hsa-miR-32-5p, hsa-miR-98-3p, hsa-miR-423-3p, and hsa-miR-1246) were upregulated in COVID-19 critical patients compared with COVID-19-negative controls. Moreover, hsa-miR-32-5p and hsa-miR-1246 levels were also altered in critical versus asymptomatic individuals. Furthermore, these microRNA target genes were related to viral infection, inflammatory response, and coagulation-related processes. In conclusion, SARS-CoV-2 promotes the alteration of microRNAs targeting the expression of key proteins for viral entry and replication, and these changes are associated with disease severity. The microRNAs identified could be taken as potential biomarkers of COVID-19 progression as well as candidates for future therapeutic approaches against this disease.

Description

MeSH Terms

SARS-CoV-2
Angiotensin-converting enzyme 2
Virus internalization
COVID-19
MicroRNAs
Virus diseases
Patient acuity
Immunoglobulin G

DeCS Terms

Enzima convertidora de angiotensina 2
Gravedad del paciente
Inmunoglobulina G
Internalización del virus
Virosis

CIE Terms

Keywords

ACE2, COVID-19, MT: Non-coding RNAs, RAB14, TMPRSS2, Biomarkers, In silico analysis, MiRNA

Citation

Calderon-Dominguez M, Trejo-Gutierrez E, González-Rovira A, Beltrán-Camacho L, Rojas-Torres M, Eslava-Alcón S, et al. Serum microRNAs targeting ACE2 and RAB14 genes distinguish asymptomatic from critical COVID-19 patients. Mol Ther Nucleic Acids. 2022 Sep 13;29:76-87